{
  "url": "https://openlegislation.uk/eu-regulation-2011-440/annex-II",
  "json_url": "https://openlegislation.uk/eu-regulation-2011-440/annex-II.json",
  "legislation": "eur/2011/440",
  "legislation_title": "Commission Regulation (EU) No 440/2011 of 6 May 2011 on the authorisation and refusal of authorisation of certain health claims made on foods and referring to children’s development and health (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-2011-440",
  "path": "annex/II",
  "kind": "annex",
  "number": "II",
  "heading": null,
  "text": "Rejected health claims\nApplication – Relevant provisions of Regulation (EC) No 1924/2006\nNutrient, substance, food or food category\nClaim\nEFSA opinion reference\nArticle 14(1)(b) health claim referring to children’s development and health\nDocosahexaenoic acid (DHA) and arachidonic acid (ARA)\nDocosahexaenoic acid (DHA) and arachidonic acid (ARA) contribute to the optimal brain development of infants and young children.\nQ-2008-212\nArticle 14(1)(b) health claim referring to children’s development and health\nLipil®\nLipil® contributes to optimal brain development of infants and young children.\nQ-2008-690\nArticle 14(1)(b) health claim referring to children’s development and health\nEnfamil® Premium\nEnfamil® Premium contributes to optimal brain development of infants and young children.\nQ-2008-691",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/2011/440/annex/II",
    "retrieved_at": "2026-11-01T14:50:10.588592+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}